LIVE NOW: FDA Workshop Focuses on Pediatric Hypertension Treatments (DAY 1)

The U.S. Food and Drug Administration hosts a public workshop at 9 a.m. ET on July 15 to discuss the development of antihypertensive therapies for pediatric patients. The workshop brings together clinicians, researchers, regulators, industry representatives, and patient advocates to explore treatment strategies, drug development...